Oral Subacute Toxicity of Nongenotoxic Hepatocarcinogen, Clofibrate in F344 Rats

비 유전독성 간발암물질일 Clofibrate의 F344 랫드에 있어서 경구 아급성독성시험

  • 정자영 (국립보건안전연구원 병리부) ;
  • 이국경 (국립보건안전연구원 병리부) ;
  • 신동환 (국립보건안전연구원 병리부) ;
  • 한범석 (국립보건안전연구원 병리부) ;
  • 김대중 (국립보건안전연구원 병리부) ;
  • 강태석 (국립보건안전연구원 연구기획과) ;
  • 김기상 (국립보건안전연구원 병리부) ;
  • 장동덕 (국립보건안전연구원 병리부) ;
  • 김창옥 (국립보건안전연구원 병리부)
  • Published : 1995.03.01

Abstract

Clofibrate, a peroxisome proliferator, is hepatocarcinogenic in rats in a dose-dependent manner. A total of 70 male and female F344 rats, 5-week-old, were divided into three groups. Rats were fed clofibrate at 0, 0.25, or 0.5% in diet for 30 days. All rats were anesthetized with $CO_2$, blood samples were taken by cardiac puncture for hematology and clinical chemistry, and the rats were killed by exsanguination. Livers, kidenys, pancreas, adrenal glands, spleen, heart, lungs, thyroid gland, reproductive organs, and digestive organs were removed, weighed, later processed, and embedded with paraplast for histological examination. The relative liver and kidney weights with respect to final body weight in the clofibrate-treated group were significantly increased compared with those of control group at all dose levels (p<0.01). It has been suggested that clofibrate may influence on hepatotoxicity by increases in peroxisomal proliferation.

Keywords